Silvercrest Asset Management Group LLC Moderna, Inc. Transaction History

Silvercrest Asset Management Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $190,274 - $313,226	-1,880 Reduced 50.0%	1,880 $223,000
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $64,774 - $106,630	640 Added 20.51%	3,760 $446,000
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $341 - $461	-4 Reduced 0.13%	3,120 $332,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $58,388 - $87,721	840 Added 36.78%	3,124 $310,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $220,200 - $289,177	2,284 New	2,284 $235,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $155,545 - $289,111	-1,230 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $6,774 - $11,055	30 Added 2.5%	1,230 $312,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $155,892 - $281,976	1,200 New	1,200 $282,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.